Biologic Switching in Psoriasis
Biologic Switching in Psoriasis jjcush@gmail.com Wed, 08/13/2025 – 12:19
RheumNow
RheumNow
RheumNow
The Patient Journey with Rheumatic Disease
The Patient Journey with Rheumatic Disease jjcush@gmail.com Wed, 08/13/2025 – 12:32
RheumNow
📊 NEW FROM EULAR: Real-world effectiveness of switching to a JAKi after first-line TNFi in PsA See how second-line t
📊 NEW FROM EULAR: Real-world effectiveness of switching to a JAKi after first-line TNFi in PsA See how second-line t
RheumNow
Wondering what rheumatoid arthritis experts think about the future of treatment? Dr. Jack Cush moderates a special Tues
Wondering what rheumatoid arthritis experts think about the future of treatment? Dr. Jack Cush moderates a special Tues https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
RheumNow
The world of rheumatoid arthritis treatment has changed dramatically. What do the experts say about the evolution of bio
The world of rheumatoid arthritis treatment has changed dramatically. What do the experts say about the evolution of bio https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
RheumNow
PT in RA – Metanalysis of 17 RCTs, 1362 pts Rx w/ aerobic/resistance exercise, hydrotherapy, manual Rx, electrotherapy,
PT in RA – Metanalysis of 17 RCTs, 1362 pts Rx w/ aerobic/resistance exercise, hydrotherapy, manual Rx, electrotherapy, https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
RheumNow
Wisdom of Medical Aphorisms
Wisdom of Medical Aphorisms jjcush@gmail.com Tue, 08/12/2025 – 17:22
RheumNow
Retrospective UK study of CPRD dataset (2012-2023) found 22 829 incident CTD Dx (81% F). Over time incidence SLE &
Retrospective UK study of CPRD dataset (2012-2023) found 22 829 incident CTD Dx (81% F). Over time incidence SLE & https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
RheumNow
Venous thromboembolism (VTE) risk goes up w/ age, obesity, estrogens; BUT a UK primary care database shows VTE risk sign
Venous thromboembolism (VTE) risk goes up w/ age, obesity, estrogens; BUT a UK primary care database shows VTE risk sign
RheumNow
Advances in Still’s disease Rx: – using IL-1 or IL-6 inhibitors 1st line – New FDA approval of emapalumab (IFNg) for MAS
Advances in Still’s disease Rx: – using IL-1 or IL-6 inhibitors 1st line – New FDA approval of emapalumab (IFNg)
RheumNow
French OL trial of PCV13 vaccination in 248 early, DMARD Naive RA pts starting MTX @ same time or after 1 month delay. 1
French OL trial of PCV13 vaccination in 248 early, DMARD Naive RA pts starting MTX @ same time or after
RheumNow
JAKne? Study of 2183 IBD pts on JAK inhib, 272 developed acne. Crude prevalence: 16% upadacitinib, 4% tofacitinib, 2% fi
JAKne? Study of 2183 IBD pts on JAK inhib, 272 developed acne. Crude prevalence: 16% upadacitinib, 4% tofacitinib, 2% fi
RheumNow
NEW EULAR 2025 POSTER: JAKi safety across ~17,000 patient-years in adults with RA, PsA, AS or nr-axSpA 🔍 View the lo
NEW EULAR 2025 POSTER: JAKi safety across ~17,000 patient-years in adults with RA, PsA, AS or nr-axSpA 🔍 View the
RheumNow
Repurposing & Pipeline (8.8.2025) Dr. Jack Cush reviews the news, reports, pipeline and drug repurposing on this w
Repurposing & Pipeline (8.8.2025) Dr. Jack Cush reviews the news, reports, pipeline and drug repurposing on this w https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
RheumNow
Chondrocalcinosis Increases Osteoarthritis Risk
Chondrocalcinosis Increases Osteoarthritis Risk jjcush@gmail.com Tue, 08/12/2025 – 10:00
RheumNow
Dermatomyositis Reviewed Researchers from the University of Pennsylvania have published an open-access review of derma
Dermatomyositis Reviewed Researchers from the University of Pennsylvania have published an open-access review of derma https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Mon, 08/11/2025 –
RheumNow
Mid East/N African Survey on #SpA referrals. – 190 Rheum responded (68% consultants, 53% tertiary,95% urban) – 89% repor
Mid East/N African Survey on #SpA referrals. – 190 Rheum responded (68% consultants, 53% tertiary,95% urban) – 89% repor https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
RheumNow
Mayo study of 659 incident RA pts finds Multimorbidity predicted 29% (OR:1.29) higher odds of RA flare, & 34% lower
Mayo study of 659 incident RA pts finds Multimorbidity predicted 29% (OR:1.29) higher odds of RA flare, & 34% lower
RheumNow
Rheums Speak: Changing Rheumatology Practices & Choices
Rheums Speak: Changing Rheumatology Practices & Choices jjcush@gmail.com Mon, 08/11/2025 – 14:29
RheumNow
2025 ACR Guidance on Diagnosis and Management of VEXAS
2025 ACR Guidance on Diagnosis and Management of VEXAS jjcush@gmail.com Mon, 08/11/2025 – 14:02
RheumNow
Inefficiencies of ANA Testing The Journal of Rheumatology has published an analysis of antinuclear antibody (ANA) mult
Inefficiencies of ANA Testing The Journal of Rheumatology has published an analysis of antinuclear antibody (ANA) mult https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Mon,
RheumNow
Novartis announced top line results of its ianalumab (VAY736;B cell inhibitor) in primary Sjögren’s dz. 2 RCTs, NEPTU
Novartis announced top line results of its ianalumab (VAY736;B cell inhibitor) in primary Sjögren’s dz. 2 RCTs, NEPTU https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
RheumNow
2025 BSR Recommendations for ANCA-associated Vasculitis The BSR and BHPR have published a guideline for the management
2025 BSR Recommendations for ANCA-associated Vasculitis The BSR and BHPR have published a guideline for the management https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Mon,
RheumNow
Rheums Speak – RA Treatment Survey
RheumNow’s August 2025 “Live Vote” surveys will examine Rheumatologist impressio
Rheums Speak – RA Treatment Survey RheumNow’s August 2025 “Live Vote” surveys will examine Rheumatologist impressio https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Mon, 08/11/2025
RheumNow
Aging Quiets Lupus UCSF researchers have found that epigentic changes in interferon genes over time may lead to lupus b
Aging Quiets Lupus UCSF researchers have found that epigentic changes in interferon genes over time may lead to lupus b
RheumNow
NEW EULAR POSTER: Real-world treatment patterns across the first 12 months of first-line advanced therapy in patients wi
NEW EULAR POSTER: Real-world treatment patterns across the first 12 months of first-line advanced therapy in patients wi https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
RheumNow
NEW EULAR POSTER: Real-world impact of second-line treatment choice in patients with PsA! 🔎View the effectiveness o
NEW EULAR POSTER: Real-world impact of second-line treatment choice in patients with PsA! 🔎View the effectiveness o https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Sun,